Skip to main content
. 2018 Aug 24;7(8):65. doi: 10.1038/s41389-018-0073-3

Fig. 3. HA/CD44 pathway regulates breast tumor stemness.

Fig. 3

a HCC1954 cells were transfected with scrambled (SCR), HAS3 (siHAS3), or CD44 siRNA (siCD44) oligos for 48 h and then the efficiency of HAS3 or CD44 silencing has been measured by qRT-PCR. siRNA oligos against CD44 mRNA was purchased by Qiagen (Flexitube siRNA SI03098123). Bars represent the mean of three independent experiments (n = 3, biological replicates) ± SD. No data were excluded from the analysis. *p-value < 0.05. **p-value < 0.01. b Representative images of the mammospheres derived from HCC1954 cells transfected as in a. c HCC1954 cells transfected as in a were plated for the sphere-forming assay. The sphere-forming efficiency (SFE) was calculated as the percentage of the number of spheres per plated cells. Values represent the mean of the number of spheres counted in 12 (n = 12) different fields. The values are representative of three independent experiments (n = 3 biological replicates). *p-value < 0.05. d HCC1954 cells were plated for the sphere-forming assay in the presence of the indicated concentration of 4-MU. SFE was calculated as in c. Values represent the mean of the number of spheres counted in 10 (n = 10) different fields. The values are representative of three independent experiments (n = 3 biological replicates). **p-value < 0.01.